Skip to main content
Fig. 5 | Molecular Medicine

Fig. 5

From: UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis

Fig. 5

Expression differences in UBE2S protein expression levels, Ki67 correlation and prognostic significance in OV patients. A Immunostaining scoring of UBE2S protein in ovarian cancer and normal ovarian tissue. B Statistical table of the correlation distribution of UBE2S protein and Ki67 expression in ovarian cancer tissue. C The relationship between UBE2S expression levels with OS in OV patients. D The relationship between UBE2S expression levels with PFS in OV patients. According to the results of IHC staining, OV patients were assigned to the UBE2S high expression group or UBE2S low expression group. Kaplan–Meier survival analysis was then carried out

Back to article page